$2.45
-0.06 | -2.39%
-0.06 | -2.39%
Today's Range:
2.45 -
2.49
PSTI Avg. Daily Volume:
138,800
05/30/12 - 10:24 AM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.51 |
| 52 Week High | 3.66 |
| 52 Week Low | 1.98 |
| Avg. Daily Vol. (Mil) | 0.14 |
| Beta (3 year) | 1.20 |
| Share Related Items | |
| Mkt Cap (Mil) | 112.50 |
| Shares Out (Mil) | 44.82 |
| Float (Mil) | 42.17 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 8.50 |
| Current Ratio | 8.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 182.93 |
| Price/Book | 2.97 |
| Price/Cash Flow | -7.90 |
| Per Share Data | |
| Earnings | -0.34 |
| Sales | 0.01 |
| Book Value | 0.85 |
| Cash Flow | -0.32 |
| Business Summary | |
|---|---|
| Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. | |
| General Information | |
| MATAM Advanced Technology Pa
Building No. 20 Haifa, 31905 |
|
| 1.0 | |
| www.pluristem.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 63 | |
| CEO: Zami Aberman | |
| Short Interest | |
| Current Month (Mil) | 0.42 |
| Previous Month (Mil) | 0.48 |
| Short Interest Ratio (Days) | 2.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -30.70 |
| Return on Investments | -38.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,422.70 | 1,317.71 | 2,830.69 | 16.53 |
Oil *
103.85
|
|
DOWN
157.99 |
DOWN
14.71 |
DOWN
40.30 |
DOWN
0.78 |
10 Yr
1.65%
SPDR Gold
149.68
|
|
-1.26%
|
-1.10%
|
-1.40%
|
-4.51%
|
Data delayed 20 minutes |
Connect with TheStreet